Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia (Q79787271)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2006

Language	Label	Description	Also known as
English	Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia	scientific article published on 26 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

2

object named as

Saliba RM

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Richard E Champlin

11

object named as

Champlin RE

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

7

object named as

Giralt S

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

12

object named as

Khouri IF

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Kebriaei P

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ma C

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ippoliti C

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Couriel DR

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

de Lima M

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Qazilbash MH

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Gajewski JL

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ha CS

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

26 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

203-209

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16799614%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705425

0 references

Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor APCs are required for maximal GVHD but not for GVL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

B cells acquire antigen from target cells after synapse formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705425

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79787271&oldid=1810059260"